October 28, 2020 Life Science Tools Product Launch

QIAGEN launches QIAseq Human Exome TR Insights, a new integrated solution for Whole Exome Sequencing

Hilden, Germany, and Germantown, Maryland, October 28, 2020 – QIAGEN today announced the launch of QIAseq Human Exome TR Insights, an innovative solution combining high-performance chemistry with robust bioinformatics to enable customers to sequence and analyze multiple types of genomic variation across the entire human exome. This integrated research solution offers rapid preparation of next-generation... Read more

October 13, 2020 PR/Corporate

QIAGEN reports strong preliminary results for third quarter of 2020

Venlo, The Netherlands, October 13, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today preliminary sales and adjusted earnings per share (EPS) results for the third quarter of 2020.  Net sales grew 26% at actual rates, and also rose 26% at constant exchange rates (CER), to $481.3 million from $382.7 million in the same period... Read more

October 5, 2020 Atomic Spectroscopy Life Science Tools Liq. Handling & Robotics

QIAGEN to complement COVID-19 testing portfolio with novel kit that simplifies and accelerates PCR analysis for research applications

Hilden, Germany, and Germantown, Maryland, October 5, 2020 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to launch a novel straightforward approach to viral RNA epidemiology that will significantly simplify and accelerate PCR analysis and remove key testing bottlenecks for SARS-CoV-2 and other RNA viruses. QIAGEN’s innovative QIAprep&amp Viral RNA UM Kit... Read more

September 17, 2020 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Bio-Techne and QIAGEN Announce Expansion and Extension of Exosome Partnership

MINNEAPOLIS, Sept. 17, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) and QIAGEN N.V. today announced the expansion and extension of a non-exclusive partnership to co-market exosome technology to existing and potential biopharma partners as well as the joint development of new exosome based products.   The agreement grants QIAGEN a non-exclusive development license to Bio-Techne’s exosome... Read more

September 16, 2020 Clinical Research/Diagn. Life Science Tools Liq. Handling & Robotics Microscopy

QIAGEN fully acquires NeuMoDx Molecular, Inc., rounding out portfolio of PCR-based diagnostic automation systems

Hilden, Germany and Ann Arbor, Michigan, September 17, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the acquisition of the remaining 80.1% of diagnostics instruments company NeuMoDx Molecular, Inc. for $248 million in cash. The move rounds out QIAGEN’s portfolio of automated molecular testing solutions based on the proven PCR technology.... Read more

September 7, 2020 Uncategorized

The following press release is in German language only – QIAGEN investiert mehr als 110 Mio. Euro in die Erhöhung der Produktions-kapazitäten für Coronavirus-Tests

Hilden, 8. September 2020 – QIAGEN hat heute angekündigt, mehr als 110 Mio. Euro in den Ausbau seiner Kapazitäten für die Fertigung von COVID-19-Testprodukten an den Standorten Hilden, Germantown (Maryland, USA) und Barcelona zu investieren. Mit dem bislang größten Investitionsprogramm in der Unternehmensgeschichte setzt QIAGEN seine Anstrengungen fort, den globalen Kampf gegen die Pandemie durch die Erhöhung von... Read more

August 24, 2020 Acad, Gov/Utilities

QIAGEN to launch easy-to-use digital test in the U.S. for rapid detection of SARS-CoV-2 antibodies following FDA emergency use authorization

Germantown, Maryland, and Hilden, Germany, August 24, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. launch of the new Access Anti-SARS-CoV-2 Total test, an easy-to-use digital test done on a portable device that provides results in about 10 minutes to detect antibodies in people exposed to the SARS-CoV-2 virus,... Read more

August 21, 2020 Lab Top-10 Product Launch

QIAGEN announces new Chairman of Supervisory Board

Venlo, The Netherlands, August 21, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced today a transition in the leadership of its Supervisory Board after an extraordinary meeting of the Supervisory Board and Managing Board. Lawrence A. Rosen, a member of the QIAGEN Supervisory Board since 2013, was appointed by the Supervisory Board as the... Read more